www.ryztx.club 提示:

本信息仅供医学专业人士参考,如果您是医学专业人士,请点击确定后进入。 如果不是,请点击取消。

取消 确定

Products and services

In 3SBio, meeting the needs of patients is the core of all actions.

Our global list of drug combinations

The following is a list of products listed by our company, which is only for medical professionals to refer to.

Etanercept (Recombinant human type II tumor necrosis factor receptor - antibody fusion protein)

Etanercept was marketed in 2005 and is the first antibody fusion protein medicine marketed in the rheumatism field of China. 3 kinds of indications were approved by the CFDA: Treatment of rheumatoid arthritis (approved in 2005), ankylosing spondylitis and psoriasis (approved in 2007). It is included in the National Medical Insurance Catalogue as a Category B drug of western medicine.

Indication Manufacturing base Dosage form & Dosage
Moderate to severe rheumatoid arthritis;
Moderate to severe plaque psoriasis (PS) in adults aged 18 or above;
Active ankylosing spondylitis.
Shanghai manufacturing base 12.5 mg/bottle; 25 mg/bottle
足球即时指数球探网 中国十大股票配资门户 股票涨跌幅限制 秒速飞艇 股票涨跌原理 微博新浪体育 竞彩足球比分 贵州快3 每日股票推荐暴涨 新快3 富余通配资 哈药股份股票行情分析 江西快三 杜德配资 配资炒股是不是不用自己的账号 竞彩篮球大小分